Stonebridge Capital Management Inc Merrimack Pharmaceuticals Inc Transaction History

Stonebridge Capital Management Inc

  • $252 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 17, 2018
BUY
$3.91 - $4.66 $52,413 - $62,467
13,405 Added 64.68%
34,130 $182,000
Q2 2018

Jul 06, 2018
BUY
$3.86 - $7.61 $1,158 - $2,283
300 Added 1.47%
20,725 $106,000
Q1 2018

Apr 16, 2018
BUY
$6.24 - $9.15 $11,700 - $17,156
1,875 Added 10.11%
20,425 $177,000
Q4 2017

Jan 29, 2018
BUY
$7.99 - $11.87 $148,214 - $220,188
18,550
18,550 $200,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Stonebridge Capital Management Inc Portfolio

Follow Stonebridge Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email